Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit

Stock Track10-28

Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.

According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.

The significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196287764?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 17:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196287764","market":"hk","top_or_hot":-1,"title":"Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit","media":"Stock Track","content":"<p>Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.</p>\n\n<p>According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.</p>\n\n<p>The significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Innovent Bio Plunges Over 13% on Dilution of Stake in Unit\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-28 17:54 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"","article_id":"1196287764","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196287764","pubTimestamp":1730109284,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Innovent Biologics Inc.  plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.According to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"股票追踪信达生物因单位股份稀释而暴跌逾13%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"Shares of Innovent Biologics Inc. (HKG:1801) plummeted 13.45% on Monday after the company announced that its unit Fortvita Biologics agreed to issue and sell new shares, diluting Innovent's stake in the unit.\nAccording to a filing on the Hong Kong stock exchange, Fortvita Biologics will issue and sell 12,808,337 new series pre-A preferred shares to affiliate Lostrancos Ventures for $20.5 million. Following the completion of this share issue, Innovent Biologics' equity interest in Fortvita Biologics will be reduced to 80% from 100% previously.\nThe significant dilution of Innovent's stake in its unit raised concerns among investors about the potential impact on the company's control and earnings from Fortvita Biologics. This negative development likely triggered the sharp sell-off in Innovent Bio's stock on Monday.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196287764"}